Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2008 1
2009 2
2010 3
2012 1
2013 3
2014 2
2015 2
2017 4
2018 2
2019 3
2020 3
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.
Desvaux E, Hemon P, Soret P, Le Dantec C, Chatzis L, Cornec D, Devauchelle-Pensec V; PRECISESADS clinical consortium; Elouej S, Duguet F, Laigle L, Poirier N, Moingeon P, Bretin S, Pers JO. Desvaux E, et al. Among authors: le dantec c. J Autoimmun. 2023 Dec 18:103147. doi: 10.1016/j.jaut.2023.103147. Online ahead of print. J Autoimmun. 2023. PMID: 38114349
[Sjögren's syndrome: Towards precision medicine].
Laigle L, Le Dantec C, Soret P, Desvaux E, Hubert S, Foulquier N, Moingeon P, Guedj M, Pers JO. Laigle L, et al. Among authors: le dantec c. Med Sci (Paris). 2022 Feb;38(2):148-151. doi: 10.1051/medsci/2021258. Epub 2022 Feb 18. Med Sci (Paris). 2022. PMID: 35179468 Free article. French. No abstract available.
Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
Bagacean C, Iuga CA, Bordron A, Tempescul A, Pralea IE, Bernard D, Cornen M, Bergot T, Le Dantec C, Brooks W, Saad H, Ianotto JC, Pers JO, Zdrenghea M, Berthou C, Renaudineau Y. Bagacean C, et al. Among authors: le dantec c. J Leukoc Biol. 2022 Feb;111(2):313-325. doi: 10.1002/JLB.4HI0620-392R. Epub 2021 Jul 20. J Leukoc Biol. 2022. PMID: 34288092
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.
Soret P, Le Dantec C, Desvaux E, Foulquier N, Chassagnol B, Hubert S, Jamin C, Barturen G, Desachy G, Devauchelle-Pensec V, Boudjeniba C, Cornec D, Saraux A, Jousse-Joulin S, Barbarroja N, Rodríguez-Pintó I, De Langhe E, Beretta L, Chizzolini C, Kovács L, Witte T; PRECISESADS Clinical Consortium; PRECISESADS Flow Cytometry Consortium; Bettacchioli E, Buttgereit A, Makowska Z, Lesche R, Borghi MO, Martin J, Courtade-Gaiani S, Xuereb L, Guedj M, Moingeon P, Alarcón-Riquelme ME, Laigle L, Pers JO. Soret P, et al. Among authors: le dantec c. Nat Commun. 2021 Jun 10;12(1):3523. doi: 10.1038/s41467-021-23472-7. Nat Commun. 2021. PMID: 34112769 Free PMC article.
Epigenetics in Primary Sjögren's Syndrome.
Bordron A, Devauchelle-Pensec V, Le Dantec C, Capdeville A, Brooks WH, Renaudineau Y. Bordron A, et al. Among authors: le dantec c. Adv Exp Med Biol. 2020;1253:285-308. doi: 10.1007/978-981-15-3449-2_11. Adv Exp Med Biol. 2020. PMID: 32445100 Review.
JAK Inhibitors and Oxidative Stress Control.
Charras A, Arvaniti P, Le Dantec C, Dalekos GN, Zachou K, Bordron A, Renaudineau Y. Charras A, et al. Among authors: le dantec c. Front Immunol. 2019 Dec 6;10:2814. doi: 10.3389/fimmu.2019.02814. eCollection 2019. Front Immunol. 2019. PMID: 31867003 Free PMC article.
Linking genetic variation with epigenetic profiles in Sjögren's syndrome.
Arvaniti P, Le Dantec C, Charras A, Arleevskaya MA, Hedrich CM, Zachou K, Dalekos GN, Renaudineau Y. Arvaniti P, et al. Among authors: le dantec c. Clin Immunol. 2020 Jan;210:108314. doi: 10.1016/j.clim.2019.108314. Epub 2019 Nov 22. Clin Immunol. 2020. PMID: 31765834
30 results